BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28335778)

  • 1. Radiation dose escalation based on FDG-PET driven dose painting by numbers in oropharyngeal squamous cell carcinoma: a dosimetric comparison between TomoTherapy-HA and RapidArc.
    Differding S; Sterpin E; Hermand N; Vanstraelen B; Nuyts S; de Patoul N; Denis JM; Lee JA; Grégoire V
    Radiat Oncol; 2017 Mar; 12(1):59. PubMed ID: 28335778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methodology for adaptive and robust FDG-PET escalated dose painting by numbers in head and neck tumors.
    Differding S; Sterpin E; Janssens G; Hanin FX; Lee JA; Grégoire V
    Acta Oncol; 2016; 55(2):217-25. PubMed ID: 26079436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility and robustness of dose painting by numbers in proton therapy with contour-driven plan optimization.
    Barragán AM; Differding S; Janssens G; Lee JA; Sterpin E
    Med Phys; 2015 Apr; 42(4):2006-17. PubMed ID: 25832091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensity modulated arc therapy implementation in a three phase adaptive (18)F-FDG-PET voxel intensity-based planning strategy for head-and-neck cancer.
    Berwouts D; Olteanu LA; Speleers B; Duprez F; Madani I; Vercauteren T; De Neve W; De Gersem W
    Radiat Oncol; 2016 Apr; 11():52. PubMed ID: 27039294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Volumetric-modulated arc therapy (RapidArc) vs. conventional fixed-field intensity-modulated radiotherapy for ¹⁸F-FDG-PET-guided dose escalation in oropharyngeal cancer: a planning study.
    Teoh M; Beveridge S; Wood K; Whitaker S; Adams E; Rickard D; Jordan T; Nisbet A; Clark CH
    Med Dosim; 2013; 38(1):18-24. PubMed ID: 22841937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of
    Berwouts D; Madani I; Duprez F; Olteanu AL; Vercauteren T; Boterberg T; Deron P; Bonte K; Huvenne W; De Neve W; Goethals I
    Head Neck; 2017 Nov; 39(11):2264-2275. PubMed ID: 28833829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of prescriptions robust against geometric uncertainties in dose painting by numbers.
    Sterpin E; Differding S; Janssens G; Geets X; Grégoire V; Lee JA
    Acta Oncol; 2015 Feb; 54(2):253-60. PubMed ID: 24991892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-guided adaptive radiation dose escalation in head and neck carcinoma: a planning study.
    Servagi-Vernat S; Differding S; Sterpin E; Hanin FX; Labar D; Bol A; Lee JA; Grégoire V
    Acta Oncol; 2015 Jul; 54(7):1008-16. PubMed ID: 25562382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary tumor delineation based on (18)FDG PET for locally advanced head and neck cancer treated by chemo-radiotherapy.
    Leclerc M; Lartigau E; Lacornerie T; Daisne JF; Kramar A; Grégoire V
    Radiother Oncol; 2015 Jul; 116(1):87-93. PubMed ID: 26088157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is IMAT the ultimate evolution of conformal radiotherapy? Dosimetric comparison of helical tomotherapy and volumetric modulated arc therapy for oropharyngeal cancer in a planning study.
    Servagi Vernat S; Ali D; Puyraveau M; Viard R; Lisbona A; Fenoglietto P; Bedos L; Makovicka L; Giraud P
    Phys Med; 2014 May; 30(3):280-5. PubMed ID: 23948367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Data-driven approach to generating achievable dose-volume histogram objectives in intensity-modulated radiotherapy planning.
    Wu B; Ricchetti F; Sanguineti G; Kazhdan M; Simari P; Jacques R; Taylor R; McNutt T
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1241-7. PubMed ID: 20800382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of PET-CT based hypofractionated accelerated dose escalation in oropharyngeal cancers: Final dosimetric results of the VORTIGERN study. (Secondary endpoint of UK NCRI portfolio: MREC No: 08/H0907/127, UKCRN ID 7341).
    Chatterjee S; Kelly C; Arunsingh M; Chakrabarty C; Mott J
    J Cancer Res Ther; 2015; 11(2):391-6. PubMed ID: 26148606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uniform FDG-PET guided GRAdient Dose prEscription to reduce late Radiation Toxicity (UPGRADE-RT): study protocol for a randomized clinical trial with dose reduction to the elective neck in head and neck squamous cell carcinoma.
    van den Bosch S; Dijkema T; Kunze-Busch MC; Terhaard CH; Raaijmakers CP; Doornaert PA; Hoebers FJ; Vergeer MR; Kreike B; Wijers OB; Oyen WJ; Kaanders JH
    BMC Cancer; 2017 Mar; 17(1):208. PubMed ID: 28327089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SmartArc-based volumetric modulated arc therapy for oropharyngeal cancer: a dosimetric comparison with both intensity-modulated radiation therapy and helical tomotherapy.
    Clemente S; Wu B; Sanguineti G; Fusco V; Ricchetti F; Wong J; McNutt T
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1248-55. PubMed ID: 20947268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptive dose painting by numbers for head-and-neck cancer.
    Duprez F; De Neve W; De Gersem W; Coghe M; Madani I
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1045-55. PubMed ID: 20643512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the type of imaging modality on target volumes delineation and dose distribution in pharyngo-laryngeal squamous cell carcinoma: comparison between pre- and per-treatment studies.
    Geets X; Daisne JF; Tomsej M; Duprez T; Lonneux M; Grégoire V
    Radiother Oncol; 2006 Mar; 78(3):291-7. PubMed ID: 16499982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatio-temporal stability of pre-treatment 18F-Fludeoxyglucose uptake in head and neck squamous cell carcinomas sufficient for dose painting.
    Rasmussen JH; Vogelius IR; Aznar MC; Fischer BM; Christensen CB; Friborg J; Loft A; Kristensen CA; Bentzen SM; Specht L
    Acta Oncol; 2015; 54(9):1416-22. PubMed ID: 26343280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I trial of 18F-Fludeoxyglucose based radiation dose painting with concomitant cisplatin in head and neck cancer.
    Rasmussen JH; Håkansson K; Vogelius IR; Aznar MC; Fischer BM; Friborg J; Loft A; Kristensen CA; Bentzen SM; Specht L
    Radiother Oncol; 2016 Jul; 120(1):76-80. PubMed ID: 26993418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helical tomotherapy versus single-arc intensity-modulated arc therapy: a collaborative dosimetric comparison between two institutions.
    Rong Y; Tang G; Welsh JS; Mohiuddin MM; Paliwal B; Yu CX
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):284-96. PubMed ID: 21236598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RapidArc, SmartArc and TomoHD compared with classical step and shoot and sliding window intensity modulated radiotherapy in an oropharyngeal cancer treatment plan comparison.
    Van Gestel D; van Vliet-Vroegindeweij C; Van den Heuvel F; Crijns W; Coelmont A; De Ost B; Holt A; Lamers E; Geussens Y; Nuyts S; Van den Weyngaert D; Van den Wyngaert T; Vermorken JB; Gregoire V
    Radiat Oncol; 2013 Feb; 8():37. PubMed ID: 23425449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.